Revolo Biotherapeutics

View the org chart displaying its 15 main executives

Most searched biographies at Revolo Biotherapeutics

• Jones Bryan, President and Chief Executive Officer
• Glen Giovanetti, Non-Executive Director
• Michael Albisser, Non-Executive Director

Create your alert
to follow the executive moves at Revolo Biotherapeutics.

Revolo Biotherapeutics has 2,292 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Lycia Therapeutics has just announced a $107 Million fundraising (posted on May 15 2024).
• Attovia Therapeutics has just announced a $150 Million fundraising (posted on May 14 2024).
• Bruker has announced the acquisition of NanoString Technologies  (posted on May 13 2024).

Popular contacts in Biotechnology

• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Carl Gordon - Director at Adicet Bio
• Khalil Barrage - Interim Chairman of the Board at Sensorion

Learn more about the Biotechnology industry >

Press releases by Revolo Biotherapeutics

• Revolo Biotherapeutics | News and Media

Social media about Revolo Biotherapeutics

• Revolo Biotherapeutics on Wikipedia, Google News & Yahoo Finance
• Revolo Biotherapeutics on LinkedIn, Twitter & YouTube

Contact by email its executives including Jones Bryan

Call Revolo Biotherapeutics at +1 929...

View the org chart

Register to receive your alert

Report an error